Yi Lü
Impact in
- Pharmaceutical Science top 0.01%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Discovery top 0.2%
Papers in
-
- Drug Solubulity and Delivery Systems 90
- Advanced Drug Delivery Systems 64
- Advancements in Transdermal Drug Delivery 22
- Biomaterials 52
- Nanoparticle-Based Drug Delivery 51
- Co-authors
- Wei Wu (174 shared papers)Jianping Qi (126 shared papers)Zhongjian Chen (38 shared papers)Haisheng He (48 shared papers)Quangang Zhu (27 shared papers)Weili Zhao (34 shared papers)Xiaochun Dong (31 shared papers)Fuqiang Hu (11 shared papers)
- Journals
- International Journal of Pharmaceutics (28 papers)Acta Pharmaceutica Sinica B (14 papers)Drug Discovery Today (10 papers)Chinese Chemical Letters (10 papers)International Journal of Nanomedicine (9 papers)
- Partner nations
- ChinaUnited StatesDenmark
In The Last Decade
Yi Lü
228 papers receiving 10.4k citations
Yi Lü's Hit Papers
Peers
Comparison fields: 5 of 128
- Pharmaceutical Science 6k
- Drug Discovery 89
- Biomaterials 2.9k
- Catalysis 301
- Polymers and Plastics 416
Countries citing papers authored by Yi Lü
This map shows the geographic impact of Yi Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Lü more than expected).
Fields of papers citing papers by Yi Lü
This network shows the impact of papers produced by Yi Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Lü. The network helps show where Yi Lü may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Lü, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 234 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adapting liposomes for oral drug delivery Hit paper breakdown → | 2018 | 569 |
| 2 | Oral delivery of proteins and peptides: Challenges, status quo and future perspectives Hit paper breakdown → | 2021 | 282 |
| 3 | 2019 | 254 | |
| 4 | 2009 | 252 | |
| 5 | 2012 | 218 | |
| 6 | 2021 | 180 | |
| 7 | 2013 | 177 | |
| 8 | 2016 | 177 | |
| 9 | 2016 | 171 | |
| 10 | 2013 | 169 | |
| 11 | 2012 | 168 | |
| 12 | 2013 | 168 | |
| 13 | 2017 | 151 | |
| 14 | 2011 | 147 | |
| 15 | 2022 | 135 | |
| 16 | 2019 | 126 | |
| 17 | 2012 | 120 | |
| 18 | 2015 | 118 | |
| 19 | 2017 | 118 | |
| 20 | 2009 | 116 |
About Yi Lü
Yi Lü is a scholar working on Pharmaceutical Science, Biomaterials, Food Science, Catalysis and Polymers and Plastics, having authored 234 papers that have together received 10.7k indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (90 papers), Advanced Drug Delivery Systems (64 papers), Nanoparticle-Based Drug Delivery (51 papers), Advancements in Transdermal Drug Delivery (22 papers), Luminescence and Fluorescent Materials (10 papers), Proteins in Food Systems (9 papers), Flame retardant materials and properties (8 papers) and Antimicrobial Peptides and Activities (6 papers). The work is most often cited by research in Pharmaceutical Science (6k citations), Drug Discovery (89 citations), Biomaterials (2.9k citations), Catalysis (301 citations) and Polymers and Plastics (416 citations). Yi Lü has collaborated with scholars based in China, United States and Denmark. Frequent co-authors include Wei Wu, Jianping Qi, Zhongjian Chen, Haisheng He, Quangang Zhu, Weili Zhao, Xiaochun Dong, Fuqiang Hu, Mengmeng Niu and Yongjiu Lv. Their work appears in journals such as International Journal of Pharmaceutics, Acta Pharmaceutica Sinica B, Drug Discovery Today, Chinese Chemical Letters and International Journal of Nanomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.